Dosage, Concentration, Route of Administration Dosage : Seek advice from an appropriately qualified and licensed physician, medical director, or other healthcare provider Concentration : 2mg/ml Route of Administration : IV/IM/SQ Resources: Precautions/Side Effects Hydroxocobalamin injections are contraindicated in people with low blood potassium or allergies to vitamin B12 or cobalt
Research Findings The research history of AOD9604 spans multiple phases of preclinical and clinical development, with generally positive findings regarding efficacy for body fat reduction and favorable safety compared to growth hormone, though ultimate regulatory approval has remained elusive
The amount printed on the vial or listed on a product page
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)